Regulation of MDR1 gene expression: Emerging concepts

Phillip Kantharidis, Sam El-Osta, Michelle De Silva, Grace Lee, Xiu F. Hu, John Zalcberg

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Drug resistance genes, such as MDR1, involved in drug efflux, and their regulation have been the subject of intense research efforts in the past 10 years. Many factors and cellular signalling pathways play a role in the regulation of MDR1 gene expression. Commonly used chemotherapeutic agents activate in vitro and in vivo general stress response pathways, potential targets of which include MDR1 and other drug resistance genes. The contribution of these agents to the emergence of drug-resistant tumour cells is of concern. Recent evidence points to a role for the epigenetic regulation of MDR1 gene expression. The identification of key components in the DNA methylation/chromatin system of gene regulation may in time lead to more informed and targeted approaches to treating drug-resistant tumours. (C) 2000 Harcourt Publishers Ltd.

Original languageEnglish
Pages (from-to)99-108
Number of pages10
JournalDrug Resistance Updates
Volume3
Issue number2
DOIs
Publication statusPublished - Apr 2000
Externally publishedYes

Cite this

Kantharidis, Phillip ; El-Osta, Sam ; De Silva, Michelle ; Lee, Grace ; Hu, Xiu F. ; Zalcberg, John. / Regulation of MDR1 gene expression : Emerging concepts. In: Drug Resistance Updates. 2000 ; Vol. 3, No. 2. pp. 99-108.
@article{3fdda473aaf348fabd1f8507d5f081fa,
title = "Regulation of MDR1 gene expression: Emerging concepts",
abstract = "Drug resistance genes, such as MDR1, involved in drug efflux, and their regulation have been the subject of intense research efforts in the past 10 years. Many factors and cellular signalling pathways play a role in the regulation of MDR1 gene expression. Commonly used chemotherapeutic agents activate in vitro and in vivo general stress response pathways, potential targets of which include MDR1 and other drug resistance genes. The contribution of these agents to the emergence of drug-resistant tumour cells is of concern. Recent evidence points to a role for the epigenetic regulation of MDR1 gene expression. The identification of key components in the DNA methylation/chromatin system of gene regulation may in time lead to more informed and targeted approaches to treating drug-resistant tumours. (C) 2000 Harcourt Publishers Ltd.",
author = "Phillip Kantharidis and Sam El-Osta and {De Silva}, Michelle and Grace Lee and Hu, {Xiu F.} and John Zalcberg",
year = "2000",
month = "4",
doi = "10.1054/drup.2000.0121",
language = "English",
volume = "3",
pages = "99--108",
journal = "Drug Resistance Updates",
issn = "1368-7646",
publisher = "Elsevier",
number = "2",

}

Regulation of MDR1 gene expression : Emerging concepts. / Kantharidis, Phillip; El-Osta, Sam; De Silva, Michelle; Lee, Grace; Hu, Xiu F.; Zalcberg, John.

In: Drug Resistance Updates, Vol. 3, No. 2, 04.2000, p. 99-108.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Regulation of MDR1 gene expression

T2 - Emerging concepts

AU - Kantharidis, Phillip

AU - El-Osta, Sam

AU - De Silva, Michelle

AU - Lee, Grace

AU - Hu, Xiu F.

AU - Zalcberg, John

PY - 2000/4

Y1 - 2000/4

N2 - Drug resistance genes, such as MDR1, involved in drug efflux, and their regulation have been the subject of intense research efforts in the past 10 years. Many factors and cellular signalling pathways play a role in the regulation of MDR1 gene expression. Commonly used chemotherapeutic agents activate in vitro and in vivo general stress response pathways, potential targets of which include MDR1 and other drug resistance genes. The contribution of these agents to the emergence of drug-resistant tumour cells is of concern. Recent evidence points to a role for the epigenetic regulation of MDR1 gene expression. The identification of key components in the DNA methylation/chromatin system of gene regulation may in time lead to more informed and targeted approaches to treating drug-resistant tumours. (C) 2000 Harcourt Publishers Ltd.

AB - Drug resistance genes, such as MDR1, involved in drug efflux, and their regulation have been the subject of intense research efforts in the past 10 years. Many factors and cellular signalling pathways play a role in the regulation of MDR1 gene expression. Commonly used chemotherapeutic agents activate in vitro and in vivo general stress response pathways, potential targets of which include MDR1 and other drug resistance genes. The contribution of these agents to the emergence of drug-resistant tumour cells is of concern. Recent evidence points to a role for the epigenetic regulation of MDR1 gene expression. The identification of key components in the DNA methylation/chromatin system of gene regulation may in time lead to more informed and targeted approaches to treating drug-resistant tumours. (C) 2000 Harcourt Publishers Ltd.

UR - http://www.scopus.com/inward/record.url?scp=0034176469&partnerID=8YFLogxK

U2 - 10.1054/drup.2000.0121

DO - 10.1054/drup.2000.0121

M3 - Review Article

VL - 3

SP - 99

EP - 108

JO - Drug Resistance Updates

JF - Drug Resistance Updates

SN - 1368-7646

IS - 2

ER -